PBM Reform, Conflicts of Interest, & Anti-Monopoly After Lina Khan
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
PBM Reform, Conflicts of Interest, & Anti-Monopoly After Lina Khan
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
What happens when the largest players in healthcare prioritize profit over patients? In this episode, we take a deep dive into the persistent monopolistic practices plaguing the industry.
Join the PUTT cocktail crew and special guest Emma Freer, Health Policy Analyst at the American Economic Liberties Project, as they explore the groundbreaking influence of Lina Khan at the FTC and her enduring impact on efforts to combat corporate monopolies across industries. From PBM reform legislation, to the dangerous conflicts of interest stemming from vertical integration across the healthcare spectrum, they break down the systemic issues affecting pharmacy and discuss actionable solutions for building a better, fairer system.
Music by JuliusH | Production & Editing by Shannon Wightman-Girard